Ravgen Settles Patent Fight With Illumina Over Genetic Testing Ravgen Settles Patent Fight With Illumina Over Genetic Testing

Gene-sequencing giant Illumina has settled a patent lawsuit brought by Maryland biotech company Ravgen, which accused Illumina ' s genetic tests of infringing its patents.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Pathology & Lab Medicine News Source Type: news